Resistance-based directed evolution of nanobodies for higher affinity in prokaryotes
- 6 September 2024
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1868 (11) , 130710
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2Biochemical Pharmacology, 2022
- Facile Affinity Maturation of Single-Domain Antibodies Using Next-Generation DNA Sequencing2022
- The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralizationMolecular Biology Reports, 2021
- Applications of nanobodies in plant science and biotechnologyPlant Molecular Biology, 2020
- Nanobody affinity improvement: Directed evolution of the anti-ochratoxin A single domain antibodyInternational Journal of Biological Macromolecules, 2020
- The Therapeutic Potential of NanobodiesBioDrugs, 2019
- Expression of single-domain antibody in different systemsApplied Microbiology and Biotechnology, 2017
- Using the β-lactamase protein-fragment complementation assay to probe dynamic protein–protein interactionsNature Protocols, 2007
- Targeting and tracing antigens in live cells with fluorescent nanobodiesNature Methods, 2006
- β-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein–protein interactionsNature Biotechnology, 2002